TM 4 SF 1 inhibits apoptosis and promotes proliferation , migration and invasion in human gastric cancer cells

Lin Liqin,Xiaoying Shen,Yan Wang,Xu-zi Cai,Huaping Shen,Guoliang Cao,Yunhai Wei

Abstract:Gastric cancer (GC) is associated with poor patient prognosis, and so it crucial to investigate the molecular mechanisms underlying the progression of GC. The aim of the present study was to investigate the role of transmembrane-4 L6 family member 1 (TM4SF1) in the progression of GC. TM4SF1 small interfering RNA (siRNA) and TM4SF1-expressing plasmids were employed to regulate TM4SF1 expression. In vitro experiments were performed to determine the effect of TM4SF1 on the expression of apoptosis-associated molecules and determine the role of TM4SF1 in apoptosis, proliferation, migration and invasion using human GC cell lines MGC803 and MKN45. The data of the present study demonstrated that TM4SF1 may regulate the expression of apoptosis-associated molecules at the mRNA and protein levels. TM4SF1 silencing reduced B-cell lymphoma 2 (Bcl2) expression, whilst caspase-3 and Bcl2-associated X expression increased, and upregulating TM4SF1 reversed these changes in GC cells. Furthermore, TM4SF1 knockdown promoted apoptosis while inhibiting the proliferation, migration and invasion of GC cells. Rescue experiments demonstrated that TM4SF1 upregulation reversed the changes induced by transfection with TM4SF1 siRNA. In summary, TM4SF1 is an anti-apoptosis protein associated with the progression of GC. Additional in vivo experiments and clinical trials are required to confirm the possible use of TM4SF1 in tumor therapy. Introduction Gastric cancer (GC) is a disease that poses a serious threat to human health and quality of life globally (1). In 2015, GC is the third highest cause of cancer-associated moralities in males and the second highest in females in China (2). Currently, patients with GC generally have a poor prognosis, and early diagnosis is important to improve patient outcomes (3). Treatment primarily comprises of combined therapy of surgery with chemotherapy and radiotherapy; however, this treatment regime has limited effectiveness. Due to the majority of patients with GC being diagnosed at advanced stages, the resection rate for GC has been reported to be ~50% (4). Chemotherapy is an adjunctive treatment that is only able to alleviate the symptoms and prolong the survival of patients with GC, rather than treating the disease (5). Whether adjuvant radiotherapy can improve the overall survival of patients with GC remains controversial (6). Developing effective therapeutic strategies based on novel targets may help to improve the overall prognosis of patients with GC. Investigating the molecular mechanisms underlying GC progression is crucial in the identification of novel therapeutic targets. Transmembrane-4 L6 family member 1 (TM4SF1), a low molecular weight protein consisting of 202 amino acids, is a member of the transmembrane-4 protein L6 superfamily. This family also includes TM4SF4, TM4SF5 and TM4SF18 (7). TM4SF1 is highly expressed in activated endothelial cells and can activate vascular endothelial growth factor (VEGF)-A or thrombin to stimulate angiogenesis (8). Additionally, TM4SF1 may also promote cell migration by increasing the formation of filopodia (9). TM4SF1 may therefore be a tumor promoter, and a number of studies have confirmed the important role of TM4SF1 in tumor progression. Cao et al (10) reported that TM4SF1 regulates pancreatic cancer migration and invasion in vitro and in vivo. Huang et al (11) reported that TM4SF1 promotes proliferation, invasion and metastasis in human liver cancer cells. Sun et al (12) confirmed that TM4SF1 regulates breast cancer cell migration and apoptosis; however, the effects of TM4SF1 on GC remain unclear. A previous study reported that TM4SF1 was overexpressed in GC (13). Based on this, it was hypothesized in the present study that TM4SF1 may be an important regulator of GC development. The aim of the present study was to assess the effects of TM4SF1 on the proliferation, migration and invasion of GC cells. These data may improve the understanding of the TM4SF1 inhibits apoptosis and promotes proliferation, migration and invasion in human gastric cancer cells YUNHAI WEI1, XIAOYING SHEN1, LIQIN LI1, GUOLIANG CAO1, XUHUA CAI2, YAN WANG1 and HUA SHEN1 Departments of 1Gastrointestinal Surgery and 2Digestion, Huzhou Central Hospital, Huzhou, Zhejiang 313000, P.R. China Received December 29, 2017; Accepted June 26, 2018 DOI: 10.3892/ol.2018.9411 Correspondence to: Dr Yunhai Wei, Department of Gastrointestinal Surgery, Huzhou Central Hospital, 198 Hongqi Road, Huzhou, Zhejiang 313000, P.R. China E-mail: yunhaiwei@126.com Abbreviations: GC, gastric cancer; VEGF, vascular endothelial growth factor; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; PVDF, polyvinylidene fluoride

Medicine